YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2025	A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia	INTERNATIONAL JOURNAL OF HEMATOLOGY
2025	Palliative Care and Hospice for Heart Failure Patients: Position Statement From the Korean Society of Heart Failure	International Journal of Heart Failure
2025	Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid Cultures	TUBERCULOSIS AND RESPIRATORY DISEASES
2025	FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004)	LUNG CANCER
2025	Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study"	CLINICAL AND MOLECULAR HEPATOLOGY
2025	Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study	JHEP REPORTS
2024	Increased risk of developing cerebro-cardiovascular diseases in police officers: a nationwide retrospective cohort study	Clinical Hypertension
2024	Development of learning-based predictive models for radiation-induced atrial fibrillation in non-small cell lung cancer patients by integrating patient-specific clinical, dosimetry, and diagnostic information	RADIOTHERAPY AND ONCOLOGY
2024	2023 Korean Society of Echocardiography position paper for diagnosis and management of valvular heart disease, part I: aortic valve disease	Journal of Cardiovascular Imaging
2024	Establishment of two human induced pluripotent stem cell lines from familial long QT syndrome type 1 patients carrying KCNQ1 mutation	STEM CELL RESEARCH
2024	The impact of shortening patient–doctor contact duration on early peritoneal dialysis-related infections	SCIENTIFIC REPORTS
2024	Establishment of a human-induced pluripotent stem cell line from a long QT syndrome type 2 patient harboring a KCNH2 mutation	STEM CELL RESEARCH
2024	Female Endoscopists in Gastroenterology	Korean Journal of Helicobacter and Upper Gastrointestinal Research
2024	Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study	LANCET ONCOLOGY
2024	Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer	ANTICANCER RESEARCH
2024	Helicobacter pylori Isolation and Antibiotic Susceptibility Testing Using Rapidly Frozen Biopsy Samples	Korean Journal of Helicobacter and Upper Gastrointestinal Research
2024	Optimizing Percutaneous Mitral Valvuloplasty for Rheumatic Mitral Stenosis ― Clinical Significance of Changes in Mitral Valve Area ―	CIRCULATION JOURNAL
2024	Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study	LIVER CANCER
2024	Cumulative Blood Pressure Load and Incident CKD	AMERICAN JOURNAL OF KIDNEY DISEASES
2024	NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations	CANCER DISCOVERY